JuliaPaladinoBrockwayMD

PubMed

• First-in-Human Evaluation of Site-Specifically LabeledZr-Pertuzumab in Patients with HER2-Positive Breast Cancer.
  Randy Yeh, Joseph A O'Donoghue, Vetri Sudar Jayaprakasam, Audrey Mauguen, Ryan Min, Sue Park, Julia P Brockway, Jacqueline F Bromberg, W Iris Zhi, Mark E Robson, Rache...> ;Journal of Nuclear Medicine. 2024 Mar 1
• 2 citations
  Quality Care in Survivorship: Lessons Learned From the ASCO Quality Oncology Practice Initiative.
  Charles L. Shapiro, Nicole Zubizarreta, Erin Moshier, Julia P Brockway, John Mandeli, Merry Jennifer Markham, Mary May Kozlik, Stephanie Crist, Paul B. Jacobsen> ;JCO Oncology Practice. 2021 Jul 20
• 5 citations
  Improving Adherence to Endocrine Therapy in Women With HR-Positive Breast Cancer.
  Julia P Brockway, Charles L. Shapiro> ;Oncology. 2018 May 15
• Automatic breast CAD results for seven categories of abnormalities.
  Brockway JP, Carruthers WB, Zapata M, Reiling RB> ;J. Clin. Oncol.. 2011-09-20
• 31 citations
  The influence of margin width and volume of disease near margin on benefit of radiation therapy for women with DCIS treated with breast-conserving therapy.
  Udo Rudloff, Edi Brogi, Anne S. Reiner, Jessica Goldberg, Julia P. Brockway, Christine A. Wynveen, Beryl McCormick, Sujata Patil, Kimberly J. Van Zee> ;Annals of Surgery. 2010 Apr 1
• The influence of margin width and volume of disease near margin on benefit of radiation therapy after breast-conserving surgery for DCIS: Results of long-term follow-up.
  Rudloff U, Brogi E, McCormick B, Brockway JP, Goldberg JI, Wynveen CA, Reiner AS, Patil S, Van Zee KJ> ;J. Clin. Oncol.. 2009-05-20
• 16 citations
  Concurrent lobular neoplasia increases the risk of ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ treated with breast-conserving therapy.
  Udo Rudloff, Edi Brogi, Julia P. Brockway, Jessica Goldberg, Milicent L. Cranor, Christine A. Wynveen, Tatjana Nehhozina, Anne S. Reiner, Sujata Patil, Kimberly J. Van...> ;Cancer. 2009 Mar 15
• 420 citations
  Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection: Objective Measurements
  Sarah A. McLaughlin, Mary J. Wright, Katherine T. Morris, Gladys L. Giron, Michelle Sampson, Julia P. Brockway, Karen Hurley, Elyn Riedel, Kimberly J. Van Zee> ;Journal of Clinical Oncology. 2008 Nov 10
• 146 citations
  Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection: Patient Perceptions and Precautionary Behaviors
  Sarah A. McLaughlin, Mary J. Wright, Katherine T. Morris, Michelle Sampson, Julia P. Brockway, Karen Hurley, Elyn Riedel, Kimberly J. Van Zee> ;Journal of Clinical Oncology. 2008 Nov 10
• Correlation of concurrent lobular neoplasia (LN) and ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ (DCIS) treated with breast-conservi...
  Rudloff U, Brogi E, Brockway JP, Wynveen CA, Nehhozina T, Reiner A, Patil S, Van Zee KJ> ;J. Clin. Oncol.. 2008-05-20
• Join now to see all